These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1300481)

  • 41. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
    Reinhard JF; Daniels AJ; Viveros OH
    Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
    Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
    Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY; Jang EH; Park CS; Kang JH
    Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 pathway and switch on GFAP expression.
    Gao K; Wang CR; Jiang F; Wong AY; Su N; Jiang JH; Chai RC; Vatcher G; Teng J; Chen J; Jiang YW; Yu AC
    Glia; 2013 Dec; 61(12):2063-77. PubMed ID: 24123203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
    Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
    Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.
    Gainetdinov RR; Fumagalli F; Jones SR; Caron MG
    J Neurochem; 1997 Sep; 69(3):1322-5. PubMed ID: 9282960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
    Lee Y; Chun HJ; Lee KM; Jung YS; Lee J
    Brain Res; 2015 Nov; 1627():233-42. PubMed ID: 26434409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-lasting CNS effects of a short-term chemical knockout of ornithine decarboxylase during development: nicotinic cholinergic receptor upregulation and subtle macromolecular changes in adulthood.
    Slotkin TA; Freibaum BD; Tate CA; Thillai I; Ferguson SA; Cada AM; Seidler FJ
    Brain Res; 2003 Aug; 981(1-2):118-25. PubMed ID: 12885432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
    Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M
    Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic gliosis induced by loss of S-100B: knockout mice have enhanced GFAP-immunoreactivity but blunted response to a serotonin challenge.
    Chang MS; Ariah LM; Marks A; Azmitia EC
    Brain Res; 2005 Jan; 1031(1):1-9. PubMed ID: 15621007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F; Bähr M; Dietz GP
    Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Cudna A; Przybyłkowski A; Członkowska A; Członkowski A
    Inflamm Res; 2009 Nov; 58(11):747-53. PubMed ID: 19777158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.
    Himeda T; Watanabe Y; Tounai H; Hayakawa N; Kato H; Araki T
    J Neural Transm (Vienna); 2006 Dec; 113(12):1887-94. PubMed ID: 16736245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain.
    Ekmark-Lewén S; Lewén A; Israelsson C; Li GL; Farooque M; Olsson Y; Ebendal T; Hillered L
    Restor Neurol Neurosci; 2010; 28(3):311-21. PubMed ID: 20479526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Imai Y; Kato H; Araki T
    Neurol Res; 2004 Sep; 26(6):644-57. PubMed ID: 15327754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.